Drug Policy Archives

FAQ: Timeline for FDA ibogaine approval

FAQ by Gregory Ferenstein

Harm reduction: An evidence-based approach to the drug war

Policy Brief by Layal Bou Harfouch

The truth about marijuana, mental illness, and violence: A review of Alex Berenson’s claims in ‘Tell Your Children’

Policy Study by Jacob James Rich and Robert Capodilupo

Drug decriminalization in Oregon: Measure 110’s impacts compared to other countries’ systems

Policy Brief by Nathan Daigneault

Psychedelic treatment for neurodegenerative disorders

Policy Brief by Madison Carlino

A framework for federal and state hemp-derived cannabinoid regulation

Policy Brief by Michelle Minton and Geoffrey Lawrence

Getting cannabis legalization right in Hawaii

Policy Brief by Michelle Minton and Geoffrey Lawrence

Ibogaine treatment for opioid use disorder

Policy Brief by Madison Carlino

A policy framework for personal psychedelics licenses

Policy Brief by Gregory Ferenstein

The implications of federal cannabis rescheduling

Policy Brief by Michelle Minton

The case for interstate marijuana commerce right now

Policy Brief by Geoffrey Lawrence and Michelle Minton

Drug Legalization Handbook

Policy Study by Geoffrey Lawrence, Jacob James Rich, Michelle Minton, Veronica Wright, Jeffrey A. Singer, Jeffrey Miron, Erin Partin, Neill Franklin, Michael Galipeau and Howard Woolridge

Modernizing psilocybin policy to improve mental health outcomes

Policy Brief by Madison Carlino

Social equity programs in marijuana legalization laws aren’t achieving goals of helping victims of the drug war

Policy Study by Geoffrey Lawrence

More Drug Policy